Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Poolbeg Pharma PLC on Wednesday announced its immunomodulator I patent has been granted in the US. The London-based ...
Poolbeg Pharma PLC 20 November 2024 Poolbeg Pharma plc - POLB 001 Patent Granted in United States Further strengthens Poolbeg's robust intellectual property portfolio 20 November...
Poolbeg Pharma PLC 18 September 2024 Poolbeg Pharma plc - Interim results for the six months to 30 June 2024 ...
Poolbeg Pharma PLC 12 August 2024 TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word...
The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not sepa ...
Poolbeg Pharma PLC 26 July 2024 Poolbeg Pharma plc Voluntary Delisting from OTCQB Market 26 July 2024- Poolbeg Pharma (AIM: POLB, OTCQB: POLBF, 'Poolbeg' or the 'Company'), a...
Poolbeg Pharma PLC 10 July 2024 TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word...
Poolbeg Pharma PLC 02 July 2024 Poolbeg Pharma plc Change of Registered Address 2 July 2024- Poolbeg Pharma (AIM: POLB, OTCQB: POLBF, 'Poolbeg' or the 'Company'), a biopharmaceutical...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.35 | -4.34782608696 | 8.05 | 8.3 | 7.6 | 907375 | 7.99298451 | DE |
| 4 | -0.2 | -2.53164556962 | 7.9 | 9.1 | 7.6 | 900217 | 8.25089203 | DE |
| 12 | -4.45 | -36.6255144033 | 12.15 | 12.15 | 7.15 | 1130854 | 8.75872767 | DE |
| 26 | -4.6 | -37.3983739837 | 12.3 | 14.25 | 7.15 | 1274953 | 11.21467663 | DE |
| 52 | -1.85 | -19.3717277487 | 9.55 | 15.7 | 7.15 | 1584783 | 10.7629704 | DE |
| 156 | -2.55 | -24.8780487805 | 10.25 | 15.7 | 4.1 | 1324092 | 8.78321333 | DE |
| 260 | -3.3 | -30 | 11 | 15.7 | 4.1 | 1321271 | 8.99624684 | DE |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
